Effect of antenatal corticosteroid administration-to-birth interval on maternal and newborn outcomes: a systematic reviewResearch in context
Summary: Background: Antenatal corticosteroids (ACS) are highly effective at improving outcomes for preterm newborns. Evidence suggests the benefits of ACS may vary with the time interval between administration-to-birth. However, the optimal ACS administration-to-birth interval is not yet known. In...
Main Authors: | Annie R.A. McDougall, Lily Aboud, Tina Lavin, Jenny Cao, Gabrielle Dore, Jen Ramson, Olufemi T. Oladapo, Joshua P. Vogel |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-04-01
|
Series: | EClinicalMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537023000937 |
Similar Items
-
The World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) Trial: study protocol for a multi-country, multi-centre, double-blind, three-arm, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at high probability of late preterm birth in hospitals in low- resource countries
by: WHO ACTION Trials Collaborators
Published: (2024-04-01) -
Late preterm antenatal corticosteroids in singleton and twin gestations: a retrospective cohort study
by: Luciana A. Vieira, et al.
Published: (2022-12-01) -
Effects of Antibiotics and Corticosteroid Eyedrops on Cellular Proliferation in Cultured Human Corneal Keratocytes
by: Kwou-Yeung Wu, et al.
Published: (2006-08-01) -
Neonatal outcomes by delivery indication after administration of antenatal late preterm corticosteroidsAJOG MFM at a Glance
by: Uma S. Deshmukh, MD, MUP, et al.
Published: (2022-11-01) -
FOXO1 Is a Key Mediator of Glucocorticoid-Induced Expression of Tristetraprolin in MDA-MB-231 Breast Cancer Cells
by: Do Yong Jeon, et al.
Published: (2022-11-01)